How is the Gain Therapeutics Inc today?

The Gain Therapeutics Inc today is trading in the down by -1.67% at 1.77.

What is Gain Therapeutics Inc Annual Net Profit?

Gain Therapeutics Inc Annual Net Profit rose 8.34% in the last year to $20.41 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Gain Therapeutics Inc Price to Earning Ratio?

Gain Therapeutics Inc Price to Earning Ratio is -2.5, which is negative.

What is Gain Therapeutics Inc Stock Price?

Gain Therapeutics Inc Stock Price fell 30.59% and underperformed its sector by 86.06% in the past year.

What is Gain Therapeutics Inc Quarterly Net profit?

Gain Therapeutics Inc Quarterly Net profit fell 12.85% YoY to $4.53 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Gain Therapeutics Inc Debt to Equity Ratio?

Gain Therapeutics Inc Debt to Equity Ratio of 0.09 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Gain Therapeutics Inc Return on Equity(ROE)?

Gain Therapeutics Inc Return on Equity(ROE) for the last financial year was -204.95%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Gain Therapeutics Inc Mutual Fund Holding?

Gain Therapeutics Inc Mutual Fund Holding increased by 0.27% in the last quarter to 3.3.

What is Gain Therapeutics Inc Institutional Holding?

Gain Therapeutics Inc Institutional Holding increased by 0.84% in the last quarter to 8.9.

Gain Therapeutics Inc XNAS: GANX

Gain Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Gain Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Gain Therapeutics Inc
Rating: 0.96483325
Author: Trendlyne DVM scores

about

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncol...

1.77 -0.03 (-1.67%)

44.51% Fall from 52W High

122.3K XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

2.8 / 100

Technically Neutral

35.8 / 100

8

1Yr Price target upside is 352%

7 analysts

Gain Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Gain Therapeutics Inc FAQ

How is Gain Therapeutics Inc today?

Gain Therapeutics Inc today is trading in the red, and is down by -1.67% at 1.77.

How has Gain Therapeutics Inc performed historically?

Gain Therapeutics Inc is currently trading down -1.67% on an intraday basis. In the past week the stock fell -1.67%. stock has been down -16.90% in the past quarter and fell -30.59% in the past year. You can view this in the overview section.